The revised guidelines also will lead to more than $20 million in extra health care costs, the research shows.

The decision by the Center for Disease Control and Prevention to stop recommending giving infants a dose of the hepatitis B ...

Federal vaccine advisers to Health Secretary Robert F. Kennedy Jr. voted in December to recommend delaying the first shot ...

Researchers found that the decision to delay the once-universal hepatitis B shot for babies will likely cause a surge in ...

HBV infection at birth or during early infancy can lead to lifelong health problems such as chronic liver disease and liver ...

Policy that recommends offering hep B vaccine at birth only to babies perceived to be at risk will lead to increased numbers ...

Amid policy shifts and a rise in misinformation fueling vaccine hesitancy, fewer infants in the U.S. are receiving the ...

The World Health Organization (WHO) released a new report on hepatitis today, marking the World Hepatitis Summit. Since 2015, ...

The Trump administration’s recommendation against universal hepatitis B vaccination for babies on the day they’re born could ...

The FDA has accepted for Priority Review the New Drug Application for bepirovirsen for the treatment of adults with chronic hepatitis B.

New research warns that missing the hepatitis B vaccine at birth sharply reduces the likelihood of infants completing the full series, raising future infection risks. The findings come as the CDC’s ...

Countries are making measurable progress in combatting viral hepatitis, but the disease remains a major global health ...